Invention Grant
- Patent Title: Rationally designed antibodies
-
Application No.: US14264975Application Date: 2014-04-29
-
Publication No.: US09409964B2Publication Date: 2016-08-09
- Inventor: Katherine S. Bowdish , Shana Frederickson , Mark Renshaw
- Applicant: Alexion Pharmaceuticals, Inc.
- Applicant Address: US CT New Haven
- Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee Address: US CT New Haven
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Main IPC: A61K35/14
- IPC: A61K35/14 ; C07K16/00 ; C07K7/00 ; C07K14/505 ; C07K14/52 ; C07K16/12 ; C07K16/18 ; C07K16/46 ; C12N5/078 ; A61K39/00 ; A61K39/40

Abstract:
Antibodies or fragments thereof having CDR regions replaced or fused with biologically active peptides are described. Flanking sequences may optionally be attached at one or both the carboxy-terminal and amino-terminal ends of the peptide in covalent association with adjacent framework regions. Compositions containing such antibodies or fragments thereof are useful in therapeutic and diagnostic modalities.
Public/Granted literature
- US20150004700A1 RATIONALLY DESIGNED ANTIBODIES Public/Granted day:2015-01-01
Information query
IPC分类: